Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-23

Clinical Trial Update: PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG

View source ↗

Summary

This document indicates a clinical trial evaluating cardiovascular events in patients with type 2 diabetes using hemoTAG is currently recruiting. The study is s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • hemoTAG

Snippet

Sponsor: Aventusoft, LLC. | Conditions: Diabetes Mellitus Type 2, Cardiovascular Diseases | Status: RECRUITING